Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

doctorwithpatient.jpg

TAVR remains a viable treatment strategy for cancer patients

Improvements in care have resulted in a growing number of patients who go on to be diagnosed with both cancer and severe aortic stenosis. TAVR appears to be an effective treatment option for those individuals, and it may help them go on to receive life-saving cancer therapies.

Nick West, MD, chief medical officer, Shockwave Medical, Johnson and Johnson Meditech, explains how the company is innovating intravascular lithotripsy (IVL) therapy devices and building clinical evidence from trials for its use in a variety of calcified lesions. There are several companies developing IVL therapy, but West says Shockwave will remain the market leader because of its nearly decade long head start in the market, strong clinical evidence and has about a 10% market penetration. #IVKL

Why Shockwave Medical is so excited about the future of intravascular lithotripsy

Nick West, MD, Shockwave Medical's chief medical officer, detailed how the company is continuing to push IVL technologies forward. "We are leading the space ... we have no intention of giving up that position," he said.

Is RFK Jr. really conducting an ‘assault on vaccines’? And more high-level news notes

The CDC has gone ahead and changed its recommendations for childhood immunizations. The gnashing of teeth has only just begun. 

U.S. FDA Sign

FDA recalls surgical packs due to risk of microbial contamination

Multiple lots of ophthalmic surgery packs manufactured by Alcon will need to be disposed of, due to an incomplete seal that could cause the sterile bandages and syringes inside to be compromised. Because of the serious health risk posed to patients, this recall has been designated Class I. 

the words "FDA recall" on a board

FDA confirms new recall after catheter sheath was left in patient’s body

This is a Class I recall, which means the FDA believes these devices could cause a serious injury or death.

President Trump

Trump regrets undergoing CT to evaluate heart health—cardiologist still baffled by his aspirin use

President Trump, 79, says he is still in excellent health. He also has no intention of cutting down on the high dose of aspirin he takes each day.

M&A mergers and acquisitions business deal

W. L. Gore & Associates to acquire medtech company behind foam-based LAAO system

Conformal Medical developed its CLAAS technology to help patients with nonvalvular atrial fibrillation reduce their risk of stroke without the use of anticoagulants. Back in August, the company raised $32 million to help ramp up research on the device.

Edwards Lifesciences Sapien M3

FDA approves TMVR system from Edwards Lifesciences for high-risk heart patients

The Sapien M3 transcatheter mitral valve replacement system is implanted using a transseptal approach. The device previously received CE mark approval in 2025.